In this episode of the Stock Alternatives Podcast, Jeff Stock sits down with Dr. Peymon Ghazi, CEO and Co-Founder of Malcova, to discuss a breakthrough imaging technology that has the potential to transform breast cancer screening and detection.

Dr. Ghazi shares how Malcova is developing a new low-dose CT-based imaging platform designed to replace traditional mammography. The technology aims to detect breast cancer earlier, improve diagnostic accuracy, reduce unnecessary biopsies, and eliminate the discomfort associated with breast compression during mammograms.

Throughout the conversation, they explore the limitations of current breast cancer screening methods, the growing challenges posed by dense breast tissue, the role of AI in radiology, and Malcova's pathway toward FDA approval and commercialization.

00:00 CT vs Mammogram Views

00:22 Podcast Intro Guest

02:08 Why Mammograms Fall Short

04:40 Biopsies Stress Inefficiency

05:48 Replacing Mammography First

06:37 Compression Pain Barrier

09:07 Radiation Dose Explained

18:09 CT Dose Breakthrough

20:20 Sensitivity Dense Breasts

22:28 Scale of Breast Cancer

27:36 Why Rates Rising

34:21 Breast Monarch Demo Setup

35:54 Prototype Patient Positioning

37:00 Men Need Screening Too

38:24 How Narrow Beam CT Works

40:53 AI Assisted Reading

46:34 Clinical Trials And FDA Path

50:22 Why Studies Take Months

54:50 Digital And Physical Twins

01:01:04 Coverage For All Bodies

01:02:22 Cost And Market Pricing

01:05:26 Beyond Breast Imaging

01:09:25 Collaboration And Closing

Thanks for listening, and please share this episode with a colleague or peer. It would really help us to grow our show and bring these advanced, tax-efficient wealth strategies to more high-income professionals. Have a great day.

-Jeff Stock

“The real advantage is not just making money—it’s keeping more of it, growing it strategically, and building wealth that compounds.”

CONNECT with Jeff & Access Exclusive Financial Insights

Get access to proven frameworks, actionable tax-reduction strategies, and time-tested principles for sophisticated investing. Plus, download free resources, access advanced market insights, and join our exclusive community of physicians, executives, business owners, and high-achievers looking to move beyond traditional financial advice.

• Join FREE at: StockAlternatives.com
• Follow Me on Social Media: LinkedIn | Facebook | Instagram | YouTube

About the Guest

Dr. Peymon Ghazi is the CEO and Co-Founder of Malcova, a medical imaging company developing next-generation breast cancer screening technology. Based in the San Francisco Bay Area, Dr. Ghazi and his team have engineered a novel Narrow Beam CT platform designed to improve breast cancer detection while reducing patient discomfort and radiation exposure.

Malcova's flagship product, Breast Monarch, is being developed to provide radiologists with highly detailed three-dimensional breast imaging that could significantly improve cancer detection rates, particularly among women with dense breast tissue.

Connect with Dr. Peymon Ghazi

• Website: https://malcova.com/
• LinkedIn: https://www.linkedin.com/in/peymon-ghazi